Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
Therapy with peptides uses those sequences already present to regulate and rejuvenate functions
Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT
01 Muscle Growth Supports increase in muscle size and cellular development
Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy
CJC-1295 is a peptide that has not been approved by the FDA for general clinical use
These are general guidelines
US$ 24.95
US$ 22.80
US$ 24.26
US$ 28.15
US$ 28.21
US$ 24.12
